Presentation Information
[SSY03-03]F-18 PET agents for personalized BNCT: current status and perspectives
Takashi Temma1,2 (1.Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2.Faculty of Pharmacy, Osaka Medical and Pharmaceutical University)